Ashvattha Therapeutics First Patient Enrolled in Phase 1/2 Study of Hydroxyl Dendrimer Imaging Agent
The hydroxyl dendrimer imaging agent selectively targets reactive macrophages and microglia and may aid visualization of neuroinflammatory progression in diseases like ALS, Alzheimer’s disease and Parkinson’s disease.
Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering
Oculi Forms Strategic Partnership with GlobalFoundries to Advance Edge Sensing Technology
Together they will manufacture OCULI SPU S12, the world’s first single-chip intelligent Software-Defined Vision Sensor.
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Perceive Bio is focused on the discovery and development of transformative gene therapies and other therapeutics for ocular diseases with high unmet need. By leveraging deep genetic understandings, their researchers have elucidated key protective biological targets.
Rockwell Automation Announces Strategic Investment in READY Robotics
They have collaborated to integrate ForgeOS with Rockwell’s line of Logix controllers and design and simulation software.
Tivity Health Acquires Industry Leading Digital Health and Wellness Platform Burnalong
The acquisition will accelerate Tivity Health’s efforts to provide consumers with a robust digital platform and extensive health and wellness content, in addition to in-person opportunities through its network of fitness locations.
Johns Hopkins Leads Nation in Research Spending for 43rd Consecutive Year
ReBokeh Vision Technologies, Inc. and Vectech Admitted into the Latest Techstars Equitech Accelerator Cohort
RealLIST Startups 2023 Includes Johns Hopkins Startups in their Baltimore Top 20 Fastest-rising Tech Companies
Johns Hopkins Technology Ventures Helps Commercialize Clinician-founded Inventions that Solve Urgent Medical Needs Worldwide
Galen Robotics and Ashvattha Therapeutics, Inc.’s Leaders Made the Top 25 Healthcare Technology Leaders of Washington, DC for 2023